WASHINGTON (AP) — The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to research experiences of doubtless harmful blood clots.
In a joint assertion in the present day, the Facilities for Illness Management and Prevention and the Meals and Drug Administration stated they have been investigating uncommon clots in six girls that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the mind and occurred along with low platelets. All six circumstances have been in girls between the ages of 18 and 48.
The experiences seem much like a uncommon, uncommon sort of clotting dysfunction that European authorities say is probably linked to a different COVID-19 vaccine not but cleared within the U.S., from AstraZeneca.
Greater than 6.8 million doses of the J&J vaccine have been administered within the U.S., the overwhelming majority with no or delicate unwanted effects.
U.S. federal distribution channels, together with mass vaccination websites, will pause the usage of the J&J shot, and states and different suppliers are anticipated to observe. The opposite two licensed vaccines, from Moderna and Pfizer, make up the huge share of COVID-19 photographs administered within the U.S. and aren’t affected by the pause.
CDC’s Advisory Committee on Immunization Practices will meet Wednesday to debate the circumstances and the FDA has additionally launched an investigation into the reason for the clots and low platelet counts.
“Till that course of is full, we’re recommending a pause in the usage of this vaccine out of an abundance of warning,” Dr. Anne Schuchat, principal deputy director of the CDC, and Dr. Peter Marks, director of the FDA’s Heart for Biologics Analysis and Analysis, stated in a joint assertion.
They’re recommending that individuals who got the J&J vaccine who’re experiencing extreme headache, stomach ache, leg ache, or shortness of breath inside three weeks after receiving the shot contact their well being care supplier.
U.S. well being authorities cautioned docs towards utilizing a typical clot remedy, the blood-thinner heparin. “On this setting, administration of heparin could also be harmful and different therapies should be given,” the FDA and CDC stated.
European authorities investigating the AstraZeneca circumstances have concluded clots seem like much like a really uncommon irregular immune response that generally strikes folks handled with heparin, resulting in a brief clotting dysfunction.
Officers say in addition they wish to educate vaccine suppliers and well being professionals in regards to the “distinctive remedy” required for any such clot.
Johnson & Johnson stated it was conscious of the experiences of “thromboembolic occasions,” or blood clots, however that no hyperlink to its vaccine had been established.
“We’re conscious that thromboembolic occasions together with these with thrombocytopenia have been reported with Covid-19 vaccines,” stated Johnson & Johnson in an announcement. “At current, no clear causal relationship has been established between these uncommon occasions and the Janssen Covid-19 vaccine.”
The J&J vaccine acquired emergency use authorization from the FDA in late February with nice fanfare, with hopes that its single-dose and comparatively easy storage necessities would pace vaccinations throughout the nation. But the shot solely makes up a small fraction of the doses administered within the U.S. as J&J has been affected by manufacturing delays and manufacturing errors on the Baltimore plant of a contractor.
Final week the drugmaker took over the power to scale up manufacturing in hopes of assembly its dedication to the U.S. authorities of offering about 100 million doses by the top of Might.
Solely about 9 million of the corporate’s doses have been delivered to states and are awaiting administration, in keeping with CDC information.
Till now concern in regards to the uncommon blood clots has centered on the vaccine from AstraZeneca, which has not but acquired authorization within the U.S. Final week, European regulators stated they discovered a potential hyperlink between the photographs and a really uncommon sort of blood clot that happens along with low blood platelets, one which appears to happen extra in youthful folks.
The European Medicines Company careworn that the advantages of receiving the vaccine outweigh the dangers for most individuals. However a number of international locations have imposed limits on who can obtain the vaccine; Britain really helpful that individuals below 30 be provided alternate options.
However the J&J and AstraZeneca vaccines are made with the identical know-how. Main COVID-19 vaccines practice the physique to acknowledge the spike protein that coats the outer floor of the coronavirus. However the J&J and AstraZeneca vaccines use a chilly virus, known as an adenovirus, to hold the spike gene into the physique. J&J makes use of a human adenovirus to create its vaccine whereas AstraZeneca makes use of a chimpanzee model.
The announcement hit U.S. inventory markets instantly, with Dow futures falling virtually 200 factors simply over two hours earlier than the opening bell. Shares of Johnson & Johnson dropped virtually 3%
At the moment’s breaking information and extra in your inbox